Share your preliminary or experimental data — positive, negative, or inconclusive. We turn it into peer-reviewed manuscripts or customized grant proposals, tailored to your specific funding destination.
The Problem We Solve
An estimated 50% of clinical trial results and the vast majority of negative preclinical findings are never published — creating publication bias and leaving your team with data that cost real money to generate, sitting uncited.
of clinical trial results are never published
Dwan et al., PLOS Medicine, 2013
of negative preclinical findings go unpublished
Fanelli, PLOS ONE, 2012
average drug development cost — much generating unpublished data
DiMasi et al., J Health Econ, 2016
The Process
Share anonymized experimental data — positive, negative, or inconclusive. No compound names or proprietary structures required.
Our Ph.D. team reviews your dataset, contextualizes it within the published literature, and identifies the most impactful framing.
We draft a peer-review-ready manuscript with you as named co-author. You review and approve all content before submission.
Your data enters the scientific record. You gain a publication, credibility, and a citable reference for your program.
Eligible Data
Negative results are especially welcome — and often the most impactful publications.
Failed leads, inactive compounds, inconclusive assays
Solubility, permeability, metabolic stability, hERG, genotoxicity
Cell-based assays, biochemical screens, dose-response data
Animal model data, PK/PD, biomarker measurements
Model outputs, virtual screening results, QSAR data
Anonymized patient biomarker datasets, PD endpoints
What You Get
Full co-author credit on the final published manuscript — permanently recognized in the scientific record.
Anonymized data only. No compound names or proprietary identifiers without your explicit written consent. Mutual NDA required.
We can target open-access journals to maximize reach and citation impact of your contribution.
From data submission to draft manuscript in 90 days. We handle writing, formatting, and journal selection.
Ph.D. scientists with records in Nature, JACS, J Med Chem, and other top-tier journals.
Strengthens your IND package, investor materials, and grant applications — turning sunk costs into scientific assets.
Get Started
No proprietary data in this form — just a description. We respond within 48 hours with an eligibility assessment.
IP & Legal Protection: All submissions are reviewed under strict confidentiality. A mutual NDA is signed before any detailed data is shared. Bridge BioHealth does not guarantee publication acceptance. Co-authorship arrangements are agreed in writing prior to submission. See full legal disclaimer below.
FAQ
Legal Disclaimer
Bridge BioHealth Consulting LLC provides scientific writing, data contextualization, and grant support services for informational and professional development purposes only. Nothing in this service constitutes legal, regulatory, financial, or investment advice. All data shared with Bridge BioHealth is subject to a mutual Non-Disclosure Agreement (NDA) signed prior to any data transfer. Bridge BioHealth does not guarantee funding outcomes, publication acceptance, or grant award. Grant proposals and manuscripts are prepared in good faith based on user-submitted data; accuracy and completeness of submitted data are the sole responsibility of the submitting party. Bridge BioHealth is not responsible for decisions made by funding agencies, journal editors, or peer reviewers. All intellectual property rights in the underlying data remain with the submitting party. Co-authorship and acknowledgment arrangements are agreed upon in writing prior to submission. This service does not create an attorney-client, fiduciary, or employment relationship. Use of this service constitutes acceptance of Bridge BioHealth's Terms of Use and Privacy Policy. © 2026 Bridge BioHealth Consulting LLC. All rights reserved.